Krsnaa Diagnostics IPO Subscription Status: FINAL
Krsnaa Diagnostics is one of the largest differentiated diagnostic service providers in India. They provide a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory, and teleradiology services to public and private hospitals, medical colleges, and community health centers pan-India.
| Investor Category | Quota | Subscription |
|---|---|---|
| Institutional (QIB) | 75% | 49.83x |
| Non-Insti. (HNI) | 15% | 116.30x |
| Retail (RII) | 10% | 41.78x |
| Employe | – | 0.98x |
| Total Subscription | 100% | 64.35x |
Krsnaa Diagnostics IPO Subscription: End of Day Update
| Day | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0.48x | 0.50x | 49.83x |
| HNI | 0.15x | 4.71x | 116.30x |
| Retail | 9.45x | 21.74x | 41.78x |
| Employee | 0.21x | 0.51x | 0.98x |
| Total | 1.98x | 5.35x | 64.35x |
Krsnaa Diagnostics IPO Subscription: Analyst Recommendations
CHOICE BROKING – SUBSCRIBE with Caution [ Report ]
“KDL is loss-making on adjusted PAT basis making P/E comparison with peers irrelevant. On P/S basis, at the higher price band of Rs954, the issue is valued at P/S of 7.6x. Based on our quick estimates, the issue is valued at P/E of 72x on FY23E compared to peers’ average P/E ~55x. Thus, KDL’s issue seems aggressively priced”
Religare broking – SUBSCRIBE FOR LONG-TERM
“With promising industry growth prospects coupled with company’s strong execution track record, we have a positive on the company for long term”
ANAND RATHI – SUBSCRIBE
“The company is available at the upper end of the IPO price band at 77.7x its FY21 earnings, with a market cap of Rs. 29,941 million. Further on FY21 earnings basis, the company is trading below the industry average of 85.99x.”
Krsnaa Diagnostics IPO Subscription: Key IPO Details
| Type | Value |
|---|---|
| Issue Size | ₹1,213.33 Cr |
| Open Date | 04/08/2021 |
| Close Date | 06/08/2021 |
| Face Value | ₹5/- per Equity Share |
| IPO Price | ₹933 – ₹954 |
| Lot Size | 15 shares |
| Lots | Min 1 – Max 13 |
Krsnaa Diagnostics IPO Subscription: Financials
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Revenue from Ops | ₹209.23 Cr | ₹258.43 Cr | ₹396.46 Cr |
| Profit before Excep* | ₹(77.73) Cr | ₹(158.33) Cr | ₹295.45 Cr |
| Profit after Tax | ₹(58.06) Cr | ₹(111.95) Cr | ₹184.93 Cr |
| EPS (Basic) | (120.28) | (216.94) | 24.51 |
| As of March 2020 | EPS (Avg*) | P/E (Floor) | P/E (Cap) |
|---|---|---|---|
| Based on basic EPS | 17.40 | 53.62 | 54.82 |
Krsnaa Diagnostics IPO: Comparison with listed industry peers
| Company | P/E (Cap) |
|---|---|
| Krsnaa Diagnostics | 54.82 |
| Highest (Dr. Lal Path) | 94.32 |
| Lowest (Metropolis Health) | 77.65 |
| Sector Avg | 85.99 |
Krsnaa Diagnostics IPO Subscription – FAQs
1. How to apply for Krsnaa Diagnostics IPO in the Retail Category?
A: An investor in the retail category may either apply through the UPI process via DEMAT account or the ASBA process via bank account
2. How to apply for Krsnaa Diagnostics IPO in HNI Category?
A: An investor can apply in the HNI category only through the ASBA process via bank account
3. Where can I find the Red Herring Prospectus (RHP) details?
A: You can visit the NSE or SEBI website for these details. Alternately you can click here: RHP
